© 2025 New Hampshire Public Radio

Persons with disabilities who need assistance accessing NHPR's FCC public files, please contact us at publicfile@nhpr.org.
Support
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Invest in local news and public media. Become a sustaining member today!

White House strikes new deals to lower prices on obesity drugs for some

By Sydney Lupkin
Published November 7, 2025 at 4:56 AM EST

The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for type 2 diabetes and obesity drugs --- but not everyone will qualify.

Copyright 2025 NPR
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.
See stories by Sydney Lupkin

You make NHPR possible.

NHPR is nonprofit and independent. We rely on readers like you to support the local, national, and international coverage on this website. Your support makes this news available to everyone.

Give today. A monthly donation of $5 makes a real difference.